12 Oversold Financial Stocks to Invest in According to Hedge Funds
On January 21, Morgan Stanley shared its 2026 market outlook, highlighting key catalysts and risk factors.
Insider Monkey Blog
11 Best Money-Making Stocks to Buy Right Now
In an environment marked by shifting rate expectations and growth volatility, investors remain focused on identifying companies capable of delivering sustainable earnings expansion...
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
TheFly reported on February 6 that Morgan Stanley increased its price target on PAHC to $49 from $45 and maintained an Equal Weight rating.
Collegium Pharmaceutical, Inc. (COLL) Gains Momentum on Jornay PM, Truist Highlights Robust Pain Portfolio
TheFly reported on February 10 that Truist Securities analyst Les Sulewski raised its price target on COLL to $58 from $55 and gave it a Buy rating. The analyst emphasized ...
Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility
Separately, on January 29, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced that it would be added to the S&P SmallCap 600 Index. It is a popular benchmark for U.S.
TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)
TheFly reported on January 29 that TD Cowen lowered its price target on LNTH to $75 from $80 and gave it a Buy rating.
Bank of America Cites Zoetis Inc.’s (ZTS) Strong Q4 Performance and Fiscal 2026 Outlook
TheFly reported on February 13 that Bank of America raised its price target for ZTS to $140 from $135 and maintained a Neutral rating on the shares. The upgraded target was...
UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade
TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11.
Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions
TheFly reported on February 4 that Barclays lowered its price target on LEGN to $80 from $90 and maintained an Overweight rating on the shares. Although the long-term forecast...
BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)’s Growth, Projecting Peak Sales Above $11B
TheFly reported on February 5 that Bank of America (BofA) initiated coverage of WVE with a Buy rating and a price target of $38.
Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares
TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares.
Fiserv (FISV) Jumps Over 6% as Activist Investor Gobbles Stake
Fiserv grew its share prices by 6.89 percent on Tuesday to finish at $63.45 apiece as investors mirrored an activist group’s acquisition of a significant stake in a bid to boost...
Under Armour (UA) Surges 8.18% on Milestone Shoe Launch
Under Armour rallied for a third straight day on Tuesday, jumping 8.18 percent to finish at $7.54 apiece as investors resumed buying positions following the launch of its final...
Waystar (WAY) Climbs 8.5% on Swing to Profits, Double-Digit Outlook
Waystar saw its share prices jump by 8.48 percent on Tuesday to close at $24.31 apiece as investors cheered its swing to profitability and a double-digit growth outlook for this...
Kyndryl (KD) Soars 11% on Financial Statement Compliance
Kyndryl Holdings rallied for a second day on Tuesday, jumping 11.03 percent to finish at $13.59 apiece as investors resumed buying positions following the successful submission...
Norwegian Cruise (NCLH) Soars 12% as Activist Firm Buys Stake
Norwegian Cruise saw its share prices jump by 12.15 percent on Tuesday to finish at $24.10 apiece as investors mimicked an activist group’s acquisition of a 10 percent stake...
National Energy (NESR) Propels to All-Time High on Earnings Beat
In an updated report, National Energy Services Reunited Corp.
eToro (ELOR) Climbs 20% on Earnings Buyout, Buyback Hike
eToro grew its share prices by 20.43 percent on Tuesday to finish at $33.07 apiece as investors gobbled up shares following a strong earnings performance and news of a higher ...
ZIM Integrated (ZIM) Soars to Record High on $4.2-Billion Takeover
ZIM Integrated rallied to an over three-year high on Tuesday, as investors gobbled up shares following news that it was set to be acquired by German shipping giant Hapag-Lloyd...
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating.
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal
TheFly reported on February 10 that Deutsche Bank lowered its price target on HIMS to $31 from $42 and maintained a Hold rating on the shares.
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81
TheFly reported on February 6 that Baird lowered its price target for HAE to $81 from $99 while maintaining an Outperform rating.
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside
TheFly reported on February 9 that Canaccord Genuity upgraded DOCS from Hold to Buy and lowered the price target to $34 from $48.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 results...
Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market
TheFly reported on February 6 that Piper Sandler raised its price target on TVTX to $38 from $35 and maintained a Neutral rating on the shares.
Truist Lowers PayPal (PYPL) Estimates Due to Slower Volume, Take Rate Compression
PayPal Holdings Inc. (NASDAQ:PYPL) is one of the best stocks under $50 to invest in.
Susquehanna Highlights Zillow’s (Z) Effective Execution, Long-Term Growth Initiatives
Zillow Group (NASDAQ:Z) is one of the best stocks under $50 to invest in.
Deutsche Bank Lowers Unity Software (U) PT to $30 While Maintaining Hold Rating
Unity Software Inc. (NYSE:U) is one of the best stocks under $50 to invest in.
Deutsche Bank Raises Centene (CNC) PT to $39 While Maintaining Hold Rating
Centene Corporation (NYSE:CNC) is one of the best stocks under $50 to invest in.
Jefferies Resumes Coverage of Antero Resources (AR) with Buy Rating and $50 PT
Antero Resources Corporation (NYSE:AR) is one of the best stocks under $50 to invest in.
BMO Capital Expresses Concern Over DraftKings’ (DKNG) 2026 Guidance, Prediction Market Competition
DraftKings Inc. (NASDAQ:DKNG) is one of the best stocks under $50 to invest in.
Guggenheim Notes Chipotle’s (CMG) Conservative 2026 Guidance, Valuation Gap
Chipotle Mexican Grill Inc. (NYSE:CMG) is one of the best stocks under $50 to invest in.
Citi Lowers Block (XYZ) PT to $85 While Maintaining Buy Rating
Block Inc. (NYSE:XYZ) is one of the best stocks under $50 to invest in.
Is Fluor Corporation (FLR) One of the Best Stocks Under $50 to Invest In?
Fluor Corporation (NYSE:FLR) is one of the best stocks under $50 to invest in.
Susquehanna Lowers Occidental Petroleum (OXY) PT Amid Near-Term Oil Oversupply Concerns
Occidental Petroleum Corporation (NYSE:OXY) is one of the best stocks under $50 to invest in.
Needham Raises Instacart (CART ) PT to $55 on Strong Execution
Maplebear Inc. (NASDAQ:CART) is one of the best stocks under $50 to invest in.
Wells Fargo Sees Buying Opportunity in CoStar (CSGP) Amid AI-Driven Market Decline
CoStar Group Inc. (NASDAQ:CSGP) is one of the best stocks under $50 to invest in.
Morgan Stanley Notes 2026 Sales From Arrowhead Pharmaceuticals, Inc. (ARWR)’s Familial Chylomicronemia Syndrome Likely Limited
TheFly reported on February 6 that Morgan Stanley lowered its price target for ARWR to $78 from $81 and kept an Equal Weight rating.
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. (ACAD) For 2026
TheFly reported on February 6 that Oppenheimer raised its price target on ACAD to $23 from $21 and maintained a Perform rating on the shares.
BoFA Notes BridgeBio Pharma, Inc. (BBIO)’s Upcoming Q4 Earnings May Have Limited Market Impact
TheFly reported on February 3 that Bank of America analyst Jason Zemansky raised its price target on BBIO to $88 from $85 and maintained a Buy rating on the shares.
RBC Cites Stable Business Model For Concentra Group Holdings Parent, Inc. (CON) Amid Macroeconomic Volatility
TheFly reported on February 2 that RBC Capital raised its price target on CON to $31 from $30 and maintained an Outperform rating.
Baird’s Model Update Suggests Alignment Healthcare, Inc. (ALHC)’s Shares Could Reach $59
TheFly reported on January 30 that Baird increased its price target on ALHC to $28 from $22 while maintaining an Outperform rating. After updating its financial model, the...
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)’s Quarterly Revenue
TheFly reported on February 6 that Canaccord reduced its price target on PBH to $86 from $88 and maintained a Buy rating on the shares. The change came after the company...
Seaport Research Downgrades Sirius XM Holdings Inc. (SIRI) to Neutral
On February 6, 2026, Seaport Research downgraded Sirius XM Holdings Inc. (NASDAQ:SIRI) to Neutral from Buy and removed its price target.
Roth Capital Raises its Price Target on TKO Group Holdings, Inc. (TKO) to $240 and Maintains a Buy Rating
On February 12, 2026, Roth Capital raised its price target on TKO Group Holdings, Inc. (NYSE:TKO) to $240 from $210 and maintained a Buy rating.
Morgan Stanley Raises its Price Target on Sphere Entertainment Co. (SPHR) to $135 and Maintains an Overweight Rating
On February 13, 2026, Morgan Stanley raised its price target on Sphere Entertainment Co.
Roth Capital Lowers its Price Target on Live Nation Entertainment, Inc. (LYV) to $174 and Maintains a Buy Rating
On February 12, 2026, Roth Capital lowered its price target on Live Nation Entertainment, Inc. (NYSE:LYV) to $174 from $176 and maintained a Buy rating.
Citi Raised its Price Target on Madison Square Garden Sports Corp. (MSGS) to $337 and Maintains a Buy Rating
On February 13, 2026, Citi analyst Jason Bazinet raised his price target on Madison Square Garden Sports Corp. (NYSE:MSGS) to $337 from $290 and maintained a Buy rating.
Hedge Fund Resource Center
